share_log

EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans

Benzinga Real-time News ·  Dec 15, 2022 12:51

Part one of a three-part series.

The first medical-grade drug candidate of the psychedelic ayahuasca is being developed.

Currently in the form of apill, the compound was conceived by Vancouver, BC-based natural drug development companyFilament Health(OTC:FLHLF).

During the development process, questions arose:

  • What exactly constitutes a dose when discussing a drug typically used within religious contexts?
  • What's the need of the drug-induced trip experience (and the typical pre-trip nausea) for obtaining health benefits?
  • How can Filament actually perform drug development tasks in a responsible manner facing ayahuasca's sacramental essence?
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment